Related Experiment Video
Updated: Jun 3, 2026

Methods for Studying the Mechanisms of Action of Antipsychotic Drugs in Caenorhabditis elegans
Published on: February 4, 2014
An open study of clozapine in the treatment of resistant schizophrenia
1NEENA DESAI, MD., DPM., Lecturer, Department of Psychiatry, LTMMC & LTMGH, SION-400 022.
Abstract:
This open study was undertaken to assess the efficacy of clozapine in resistant schizophrenics, its side effects and safety profile and the mean dose required. Sample consisted of 28 patients who had been previously treated with neuroleptics and ECTs. A special proforma was prepared for recording the psychopathology and side effect profile. The complete blood count, differential count and BPRS scores were recorded weekly for a period of 3 months. Within 1 month of treatment on a dose range of 100-200 mg/day a 25%-50% decline in the BPRS score was noticed, the mean dose required was 241 mg/day. Sedation and sialorrhoea constituted the commonest side effects in 90% patients. No case of agranulocytosis was reported. The implications of the study are discussed.
Related Concept Videos
Psychosis: Goals of Pharmacotherapy
Drug Therapy
Antianxiety Medications
Treatment Resistent Cancers
Psychosis and Antipsychotic Drugs: Overview
Treatment Resistant Cancers
Antipsychotic Drugs: Typical and Atypical Agents